DXCM
Price
$118.24
Change
+$1.62 (+1.39%)
Updated
Dec 4, 6:59 PM EST
65 days until earnings call
ISRG
Price
$311.84
Change
-$3.36 (-1.07%)
Updated
Dec 4, 6:59 PM EST
51 days until earnings call
Ad is loading...

DXCM vs ISRG ᐉ Comparison: Which is Better to Invest?

Header iconDXCM vs ISRG Comparison
Open Charts DXCM vs ISRGBanner chart's image
DexCom
Price$118.24
Change+$1.62 (+1.39%)
Volume$1.7M
CapitalizationN/A
Intuitive Surgical
Price$311.84
Change-$3.36 (-1.07%)
Volume$675.88K
CapitalizationN/A
View a ticker or compare two or three
DXCM vs ISRG Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
DXCM vs. ISRG commentary
Dec 05, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a Buy and ISRG is a Hold.

COMPARISON
Comparison
Dec 05, 2023
Stock price -- (DXCM: $118.26 vs. ISRG: $311.93)
Brand notoriety: DXCM: Not notable vs. ISRG: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DXCM: 46% vs. ISRG: 55%
Market capitalization -- DXCM: $43.5B vs. ISRG: $110.9B
DXCM [@Medical Specialties] is valued at $43.5B. ISRG’s [@Medical Specialties] market capitalization is $110.9B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $6.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 1 FA rating(s) are green whileISRG’s FA Score has 1 green FA rating(s).

  • DXCM’s FA Score: 1 green, 4 red.
  • ISRG’s FA Score: 1 green, 4 red.
According to our system of comparison, ISRG is a better buy in the long-term than DXCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 4 TA indicator(s) are bullish while ISRG’s TA Score has 6 bullish TA indicator(s).

  • DXCM’s TA Score: 4 bullish, 4 bearish.
  • ISRG’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, ISRG is a better buy in the short-term than DXCM.

Price Growth

DXCM (@Medical Specialties) experienced а +3.76% price change this week, while ISRG (@Medical Specialties) price change was -0.97% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.05%. For the same industry, the average monthly price growth was +9.76%, and the average quarterly price growth was -10.76%.

Reported Earning Dates

DXCM is expected to report earnings on Feb 08, 2024.

ISRG is expected to report earnings on Jan 25, 2024.

Industries' Descriptions

@Medical Specialties (+4.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for DXCM with price predictions.
OPEN
A.I.dvisor published
a Summary for ISRG with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ISRG($111B) has a higher market cap than DXCM($43.5B). DXCM has higher P/E ratio than ISRG: DXCM (123.46) vs ISRG (72.99). ISRG YTD gains are higher at: 17.554 vs. DXCM (4.433). ISRG has higher annual earnings (EBITDA): 2.09B vs. DXCM (787M). ISRG has more cash in the bank: 6.48B vs. DXCM (3.24B). ISRG has higher revenues than DXCM: ISRG (6.85B) vs DXCM (3.4B).
DXCMISRGDXCM / ISRG
Capitalization43.5B111B39%
EBITDA787M2.09B38%
Gain YTD4.43317.55425%
P/E Ratio123.4672.99169%
Revenue3.4B6.85B50%
Total Cash3.24B6.48B50%
Total Debt2.72BN/A-
FUNDAMENTALS RATINGS
DXCM vs ISRG: Fundamental Ratings
DXCM
ISRG
OUTLOOK RATING
1..100
2826
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
3036
SMR RATING
1..100
4963
PRICE GROWTH RATING
1..100
4031
P/E GROWTH RATING
1..100
9044
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ISRG's Valuation (88) in the Medical Specialties industry is in the same range as DXCM (89). This means that ISRG’s stock grew similarly to DXCM’s over the last 12 months.

DXCM's Profit vs Risk Rating (30) in the Medical Specialties industry is in the same range as ISRG (36). This means that DXCM’s stock grew similarly to ISRG’s over the last 12 months.

DXCM's SMR Rating (49) in the Medical Specialties industry is in the same range as ISRG (63). This means that DXCM’s stock grew similarly to ISRG’s over the last 12 months.

ISRG's Price Growth Rating (31) in the Medical Specialties industry is in the same range as DXCM (40). This means that ISRG’s stock grew similarly to DXCM’s over the last 12 months.

ISRG's P/E Growth Rating (44) in the Medical Specialties industry is somewhat better than the same rating for DXCM (90). This means that ISRG’s stock grew somewhat faster than DXCM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMISRG
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
47%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
55%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
69%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
62%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 5 days ago
69%
Declines
ODDS (%)
Bearish Trend 27 days ago
71%
Bearish Trend 7 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
50%
Aroon
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
62%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AYTU2.380.04
+1.71%
Aytu BioPharma
ZGN11.850.09
+0.77%
Ermenegildo Zegna NV
ROL41.130.22
+0.54%
Rollins
GNFT3.26N/A
-0.14%
Genfit SA
UAN68.21-1.27
-1.83%
CVR Partners LP

DXCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with PODD. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then PODD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
+1.41%
PODD - DXCM
58%
Loosely correlated
+0.96%
ISRG - DXCM
52%
Loosely correlated
-1.04%
PEN - DXCM
48%
Loosely correlated
+0.35%
INSP - DXCM
46%
Loosely correlated
+2.95%
ABT - DXCM
46%
Loosely correlated
+0.30%
More

ISRG and

Correlation & Price change

A.I.dvisor indicates that over the last year, ISRG has been loosely correlated with SYK. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ISRG jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ISRG
1D Price
Change %
ISRG100%
-1.04%
SYK - ISRG
62%
Loosely correlated
-2.30%
RVTY - ISRG
61%
Loosely correlated
+0.53%
ABT - ISRG
60%
Loosely correlated
+0.30%
IDXX - ISRG
59%
Loosely correlated
+7.05%
EW - ISRG
56%
Loosely correlated
+1.20%
More